Ron J. Keizer

3.0k total citations · 1 hit paper
60 papers, 2.0k citations indexed

About

Ron J. Keizer is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Statistics and Probability. According to data from OpenAlex, Ron J. Keizer has authored 60 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 15 papers in Pediatrics, Perinatology and Child Health and 11 papers in Statistics and Probability. Recurrent topics in Ron J. Keizer's work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Statistical Methods in Clinical Trials (11 papers) and Pharmaceutical studies and practices (10 papers). Ron J. Keizer is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (17 papers), Statistical Methods in Clinical Trials (11 papers) and Pharmaceutical studies and practices (10 papers). Ron J. Keizer collaborates with scholars based in Netherlands, United States and Sweden. Ron J. Keizer's co-authors include Jos H. Beijnen, Alwin D. R. Huitema, Jan H.M. Schellens, Srijib Goswami, Adam Frymoyer, Rob ter Heine, Hilde Rosing, Robert S. Jansen, Bas Thijssen and Henry J.C. de Vries and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Trends in Pharmacological Sciences and Pharmaceutical Research.

In The Last Decade

Ron J. Keizer

56 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies

2010 558 citations Ron J. Keizer, Alwin D. R. Huitema et al. Clinical Pharmacokinetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ron J. Keizer Netherlands	20	386	364	350	310	306	60	2.0k
Rob ter Heine Netherlands	26	404 1.0×	453 1.2×	266 0.8×	263 0.8×	309 1.0×	163	2.2k
Imke H. Bartelink Netherlands	24	269 0.7×	458 1.3×	375 1.1×	246 0.8×	206 0.7×	64	1.9k
Martin Bergstrand Sweden	17	487 1.3×	425 1.2×	311 0.9×	166 0.5×	340 1.1×	38	2.5k
Mario Regazzi Italy	36	430 1.1×	410 1.1×	369 1.1×	311 1.0×	631 2.1×	136	3.6k
Young‐A Heo New Zealand	20	236 0.6×	218 0.6×	561 1.6×	163 0.5×	257 0.8×	53	1.8k
Christopher Banfield United States	30	426 1.1×	515 1.4×	328 0.9×	447 1.4×	301 1.0×	88	2.8k
Joan Korth‐Bradley United States	26	776 2.0×	452 1.2×	546 1.6×	223 0.7×	504 1.6×	89	2.8k
Nitin Mehrotra United States	22	166 0.4×	395 1.1×	360 1.0×	211 0.7×	130 0.4×	59	1.8k
Gabriele Kirchner Germany	25	209 0.5×	366 1.0×	356 1.0×	119 0.4×	339 1.1×	54	2.0k
Leo Stolk Netherlands	23	623 1.6×	249 0.7×	468 1.3×	831 2.7×	202 0.7×	68	2.4k

Countries citing papers authored by Ron J. Keizer

Since Specialization

Citations

This map shows the geographic impact of Ron J. Keizer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron J. Keizer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron J. Keizer more than expected).

Fields of papers citing papers by Ron J. Keizer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron J. Keizer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron J. Keizer. The network helps show where Ron J. Keizer may publish in the future.

Co-authorship network of co-authors of Ron J. Keizer

This figure shows the co-authorship network connecting the top 25 collaborators of Ron J. Keizer. A scholar is included among the top collaborators of Ron J. Keizer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron J. Keizer. Ron J. Keizer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dvorak, Christopher C., Soohee Cho, Christine S. Higham, et al.. (2025). High Melphalan Exposure Increases the Risk of Graft-Versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation. Transplantation and Cellular Therapy. 31(6). 384.e1–384.e15.

Alsoud, Dahham, Dirk Jan A. R. Moes, Zhigang Wang, et al.. (2024). Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic Drug Monitoring. 46(3). 291–308. 8 indexed citations

Bourgonje, Arno R., Marla C. Dubinsky, Ron J. Keizer, Erwin Dreesen, & Paola Mian. (2024). Model-informed precision dosing in inflammatory bowel diseases. Trends in Pharmacological Sciences. 46(1). 9–19. 1 indexed citations

Keizer, Ron J., et al.. (2024). Performance of Eight Infliximab Population Pharmacokinetic Models in a Cohort of Dutch Children with Inflammatory Bowel Disease. Clinical Pharmacokinetics. 63(4). 529–538. 2 indexed citations

Keizer, Ron J., et al.. (2024). Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole. Clinical Pharmacokinetics. 63(5). 645–656. 1 indexed citations

Daly, Bobby, et al.. (2023). Clinical decision support for chemotherapy‐induced neutropenia using a hybrid pharmacodynamic/machine learning model. CPT Pharmacometrics & Systems Pharmacology. 12(11). 1764–1776. 13 indexed citations

Lü, Ying, Sandhya Kharbanda, Christopher C. Dvorak, et al.. (2022). Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell Transplantation. Pharmaceutics. 14(11). 2462–2462. 6 indexed citations

Frymoyer, Adam, et al.. (2022). Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data Set. Clinical Pharmacokinetics. 62(1). 67–76. 9 indexed citations

Heine, Rob ter, Ron J. Keizer, Elise J. Smolders, et al.. (2020). Prospective validation of a model‐informed precision dosing tool for vancomycin in intensive care patients. British Journal of Clinical Pharmacology. 86(12). 2497–2506. 29 indexed citations

10.

Frymoyer, Adam, et al.. (2020). Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children’s Hospital. Frontiers in Pharmacology. 11. 551–551. 48 indexed citations

11.

Zwart, Tom C., Dirk Jan A. R. Moes, Paul J. M. van der Boog, et al.. (2020). Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients. Clinical Pharmacokinetics. 60(2). 191–203. 12 indexed citations

12.

Heine, Rob ter, et al.. (2019). Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin. Clinical Pharmacokinetics. 58(6). 815–826. 19 indexed citations

13.

Keizer, Ron J., et al.. (2017). "Turn laterally to the left!". The need for uniform C-arm communication terminology during orthopaedic trauma surgery.. Data Archiving and Networked Services (DANS). 83(1). 146–152. 7 indexed citations

14.

Keizer, Ron J., Gordon Munro, Arne Mørk, et al.. (2016). Pharmacokinetic/Pharmacodynamic Relationship of Gabapentin in a CFA-induced Inflammatory Hyperalgesia Rat Model. Pharmaceutical Research. 33(5). 1133–1143. 12 indexed citations

15.

Keizer, Ron J., et al.. (2013). Development of an Extended-Release Formulation of Capecitabine Making Use of In Vitro–In Vivo Correlation Modelling. Journal of Pharmaceutical Sciences. 103(2). 478–484. 10 indexed citations

16.

Jansen, Robert S., Hilde Rosing, Pierre W. Wijermans, et al.. (2012). Decitabine triphosphate levels in peripheral blood mononuclear cells from patients receiving prolonged low-dose decitabine administration: a pilot study. Cancer Chemotherapy and Pharmacology. 69(6). 1457–1466. 14 indexed citations

17.

Keizer, Ron J., et al.. (2011). Model‐Based Evaluation of Similarity in Pharmacokinetics of Two Formulations of the Blood‐Derived Plasma Product C1 Esterase Inhibitor. The Journal of Clinical Pharmacology. 52(2). 204–213. 1 indexed citations

18.

Keizer, Ron J., Iñaki F. Trocóniz, Alwin D. R. Huitema, et al.. (2010). Predictive ability of a semi-mechanistic model for neutropenia in the development of novel anti-cancer agents: two case studies. Investigational New Drugs. 29(5). 984–995. 19 indexed citations

19.

Dorlo, Thomas P. C., P. P. A. M. van Thiel, Alwin D. R. Huitema, et al.. (2008). Pharmacokinetics of Miltefosine in Old World Cutaneous Leishmaniasis Patients. Antimicrobial Agents and Chemotherapy. 52(8). 2855–2860. 118 indexed citations

20.

Keizer, Ron J., Miren Zamacona, Mendel Jansen, et al.. (2008). Application of population pharmacokinetic modeling in early clinical development of the anticancer agent E7820. Investigational New Drugs. 27(2). 140–152. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact